Citadel Advisors’s Nature's Sunshine NATR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-100
Closed -$1.47K – 15221
2024
Q4
$1.47K Sell
100
-1,000
-91% -$14.6K ﹤0.01% 14185
2024
Q3
$15K Sell
1,100
-1,000
-48% -$14.3K ﹤0.01% 12994
2024
Q2
$31.6K Buy
+2,100
New +$35.9K ﹤0.01% 12211
2024
Q1
– Sell
-1,900
Closed -$32.9K – 15177
2023
Q4
$32.9K Buy
1,900
+1,800
+1,800% +$31.1K ﹤0.01% 12196
2023
Q3
$1.66K Buy
+100
New +$1.52K ﹤0.01% 13827
2023
Q2
– Sell
-200
Closed -$2.04K – 14921
2023
Q1
$2.04K Hold
200
– – ﹤0.01% 14215
2022
Q4
$1.66K Buy
+200
New +$1.69K ﹤0.01% 14438

Other funds holding NATR

Citadel Advisors's NATR Position: Q2 2026 in Review

Citadel Advisors sold out of Nature's Sunshine (NATR) in Q2 2026, closing a stake of 43,665 shares — an estimated $1.05M sold.

Citadel Advisors first reported a position in NATR in Q3 2013 and held it in 21 quarters. The position peaked at $1.05M in Q1 2026. 153 funds tracked by Wall St. Rank hold NATR as of Q2 2026.

  • Citadel Advisors reported no remaining Nature's Sunshine position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 43,665 Nature's Sunshine shares in Q2 2026, an estimated $1.05M.
  • Citadel Advisors first reported a position in Nature's Sunshine in Q3 2013 and held it in 21 quarters.
  • Citadel Advisors's Nature's Sunshine position peaked at $1.05M in Q1 2026.
  • 153 funds tracked by Wall St. Rank held Nature's Sunshine as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.